Drug profile · INN
golodirsen
VYONDYS 53
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
golodirsen (VYONDYS 53) is an FDA-listed pharmaceutical active ingredient. Associated with Sarepta Therapeutics. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN golodirsen
Brand VYONDYS 53
Route INTRAVENOUS
Formulation SOLUTION
Originator Sarepta Therapeutics
Frequently asked questions
What is golodirsen?
golodirsen (VYONDYS 53) is an FDA-listed pharmaceutical active ingredient. Associated with Sarepta Therapeutics. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for golodirsen?
VYONDYS 53 is a marketed brand name for golodirsen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of golodirsen?
golodirsen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.